François Lauzier
Chercheur universitaire clinicien
Axe Santé des populations et pratiques optimales en santé
Dernières nouvelles
Voir tout
Communiqués
Une plateforme internationale adaptative d’essais cliniques sur les traumatismes craniocérébraux novatrice financée à hauteur de 4,8 M $
Communiqués
IRSC : Un financement de plus de 11 millions de dollars pour 15 projets de recherche
Nouvelles
[ULaval Nouvelles] Soins aux victimes de traumatismes graves: des écarts préoccupants entre hôpitaux
Publications
Voir tout-
article Thabane A, Heels-Ansdell D, Zytaruk N, Johnstone J, Lauzier F, Arabi YM, Muscedere J, Clarke F, Hand L, Watpool I, Porteous R, Sandu G, Santos M, Tassy D, Marshall J, McIntyre L, Ball I, Rochwerg B, Karachi T, Zarychanski R, Marquis F, Friedrich JO, Lysecki P, Cook D and
Coenrollment of critically ill patients in PROSPECT: characteristics and association with treatment efficacy and safety
Trials 26 (1), 2025.
-
article Deane AM, Heels-Ansdell D, Lauzier F, Adhikari NKJ, Cook D
Reply to Wang et al.: Closing the Gaps: Enhancing Risk Factor Evaluation for Patient-Important Upper Gastrointestinal Bleeding
Am J Respir Crit Care Med 2025.
-
article Chassé M, Shankar JJS, Fergusson DA, English SW, Dhanani S, Lauzier F, Turgeon AF, Ball I, Darvesh S, Neves Briard J, Essig M, Boucher-Roy D, Titova P, Lebrasseur M, Couillard P, Kramer A, D'Aragon F, Hannouche M, Tampieri D, Meade MO, Menon BK, Green R, Baker AJ, Burns KEA, Zarychanski R, Shahin J, Boyd JG, Binnie A, Gibson A, Wang HT, Shemie S and
Computed Tomography Perfusion and Angiography for Death by Neurologic Criteria
JAMA Neurol 82 (9), 2025.
Projets
- The NeurO2 study: optimal brain oxygenation in neurocritically ill patients, du 2020-10-01 au 2026-03-31
- Anticoagulation and Convalescent Plasma ICU Trials in REMAP-CAP, du 2020-06-01 au 2026-03-31
- Development of Interdisciplinary Strategies to Prevent Chronic Opioid Use in Adult Trauma Patients, du 2021-04-01 au 2026-03-31
- Reducing low-value practices in acute trauma care: a pragmatic cluster randomized controlled trial, du 2023-04-01 au 2027-03-31
- activated CHARcoal in Poisoned Patients (CHARPP): a pilot Randomized Controlled Trial, du 2023-04-01 au 2026-03-31
- BRAINapt: TBI International Adaptive Platform Trial, du 2024-04-01 au 2029-03-31
- Improving mental health pratices recovering from traumatic injuries: Identifying prioritiez based on knowledge to practice gaps and interested parties needs and preferences, du 2024-04-01 au 2028-03-31
- Optimizing Patient-centred outcomes Using opioid minimization Strategies (OPUS) Pilot Trial, du 2025-04-01 au 2028-03-31
- Co-Design and Usability Testing of a Sustainable Behavioural Intervention to Optimise Opioid Use Following Traumatic Injuries, du 2025-04-01 au 2027-03-31
- Platelet Transfusion Domain of the Canadian Critical Care Comparative Effectiveness Platform(e) d'Évaluation Clinique Comparée en soins Critiques - (CEPEC), du 2025-04-01 au 2029-03-31
- Canadian Traumatic brain injury Research Consortium, du 2015-12-01 au 2025-03-31
- The Ottawa SHA search algorithm : a novel and innovative primary subarachnoïd hemorrhage prediction model using health administrative data : facilitating large-scale population -based epidemiologic studies., du 2017-05-17 au 2025-03-31
- Improving the quality of Canadian pediatric injury care: identifying priorities based on evidence, practice variations and stakeholder needs and preferences, du 2021-10-01 au 2025-09-30
- Fluids in Septic Shock (FISSH): a randomized controlled trial., du 2020-04-01 au 2023-11-30
- BRAINapt: TBI International Platform Trial, du 2023-10-01 au 2025-03-31
- BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections, du 2022-09-01 au 2025-03-31